Featured Post

Attacks in Russian schools inspired by Columbine massacre

Three separate bloodbaths at Russian schools recently are all linked by the teenage attackers 'worshipping' the perpetrators of...

Monday, October 31, 2016

DRUG DEALER $4.6 billion depression drugs sales in the US

The US market for major depressive disorders (MDD) will rise from $2.4 billion in 2015 to $4.6 billion by 2025, at an compound annual growth rate of 6.6%, according to GlobalData.
The company’s report states that the US will not only remain the largest major market for MDD drugs, but will extend its lead over other countries, primarily due to the wide-ranging availability of treatments and the commercial success of atypical antipsychotics, which generated 39% of the sales in the US market in 2015.
GlobalData analyst Christos Michaelides, Ph.D., commented: “As a class, atypical antipsychotics are due to retain their market share during the forecast period and are expected to generate sales of $1.9 billion in 2025, which will represent a little over two-fifths of the US MDD market... While Abilify generated the greatest revenue for the atypical antipsychotics in 2015, its sales will remain static during the forecast period. This will be due to increasing use of generic aripiprazole, and competition from Otsuka/Lundbeck’s Rexulti, which is due to see its US sales increase rapidly to just under $588 million by 2025.”
GlobalData estimates that five products in the late-stage pipeline will enter the MDD market in the US during the forecast period: Alkermes’ ALKS-5461, Allergan/Gedeon Richter/Mitsubishi Tanabe’s Vraylar, Axsome Therapeutics’ AXS-05, Janssen’s esketamine, and Allergan’s rapastinel. By 2025, GlobalData expects that these pipeline drugs will generate over $800 million, of which Janssen’s esketamine will achieve the greatest share.
Depression Drugs Sales in the US to Reach $4.6 billion by 2025 Oct 24, 2016



The Citizens Commission on Human Rights (CCHR), a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health, is calling on the Federal Drug Administration (FDA) to examine the facts behind the heavy drugging of children under the misdiagnosis of [Attention Deficit Disorder (ADHD)](https://www.youtube.com/watch?v=TlvJTYbUFuk). 

CLEARWATER, FL, October 25, 2016 As ADHD Awareness Month draws to a close, CCHR Florida is calling on the FDA to examine the facts behind the heavy drugging of children under the misdiagnosis of ADHD. According to QuintilesIMS, the first independent, objective source of information about the pharmaceutical industry, in the United States alone, 8.4 million children are being prescribed psychiatric drugs and more than 1 million of these children are under the age of five. [1] 

Parents are being told that their child has a mental disorder but in actual fact there is no independent, valid test for ADHD nor is there any data to indicate that ADHD is due to a brain malfunction yet the number of children being labeled with a brain-disorder continues to climb, stated Diane Stein, President of [CCHR Florida](http://www.cchrflorida.org/). 

In fact a recent study conducted by the CDC showed that approximately 11% of children 4-17 years of age have been diagnosed with ADHD as of 2011 [2] and the percentage being diagnosed continues to increase with 6.4 million children diagnosed in 2011. 

Pediatric occupational therapist Angela Hanscom has traced back the reason that children are being increasingly diagnosed with ADHD. [3] 


She notes that kids are forced to stay in an upright position for hours on end; gone are the days when children rolled down hills, climbed trees, spun in circles. Recesses are abbreviated because of increasing academic demands. Kids rarely play outdoors now. In other words, children do not move nearly as much as they need to. 


Ms. Hanscom tested several classrooms and discovered most children had very poor core strength and balance. In fact, she discovered that only one in twelve children were normal in this regard. 


Could it be that fidgeting is a natural response to an environment where chdren are not allowed to move, and is a desperate and natural response to the unnatural demands of the educational system? 


The psychiatrists attitude of fixing a problem by quieting a childs movement is not just ignorant, it is dangerous. The two commonly prescribed drugs for ADHA, Ritalin and Adderall, carry Black box Warnings and side effects can include agitation, aggression, mood swings, depression, thoughts of suicide, fast/pounding/irregular heartbeat, seizures, slurred speech and confusion. 


Dangerous psychiatric drugs are being given to infants and toddlers despite the known debilitating side effects of death, homicides and suicides that are reported in older children and adults taking these medications, [4] stated Diane Stein. Why is this being done despite the known risks? Because a psychiatrist prescribing drugs can make up to four times as much as one who doesnt and drugs prescribed for ADHD alone make billions every year. It is all about the money. [5] 


Individuals are invited to the center, located at 109 N. Fort Harrison Avenue in downtown Clearwater, to learn more about the dangers associated with psychiatric drugs as well as alternatives to medication. To learn more, please call 727-442-8820 or visit [www.cchrflorida.org](http://www.cchrflorida.org/). 


About CCHR: 


Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHRs mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. 


It was L. Ron Hubbard, the founder of Scientology, who brought the terror of psychiatric imprisonment to the notice of the world. In March 1969, he said, Thousands and thousands are seized without process of law, every week, over the free world tortured, castrated, killed. All in the name of mental health. 


SOURCES: 


[1] cchrint.org/issues/childmentaldisorders/ 


[2] cdc.gov/ncbddd/adhd/features/key-findings-adhd72013.html 


[3] washingtonpost.com/news/answer-sheet/wp/2014/07/08/why-so-many-kids-cant-sit-still-in-school-today/ 


[4] cchrflorida.org/infants-being-given-psychiatric-drugs-on-the-rise/ 


[5] apa.org/monitor/2012/06/prescribing.aspx




The Hidden Epidemic Exposed: The New Tardive Dyskinesia (TD) Resource Center Peter Breggin, MD October 28, 2016

“My drug dealer was a doctor, doctor
Had the plug from Big Pharma, Pharma
He said that he would heal me, heal me

But he only gave me problems, problems.”

In new song, Macklemore condemns ‘big pharma,’ docs for opioid addiction October 27, 2016

Although the Federal Drug Administration is thought to serve American consumers by keeping them safe and well-informed, they are doing just the opposite by controlling the media and science press in order to create misleading and one-sided articles.
An investigation into documents released through the Freedom of Information Act by Scientific American revealed that the FDA uses a variety of tactics to prevent the full truth from being revealed about a certain product. The biggest tactic is the “close-hold embargo,” where they invite a select few news sites to a briefing about the to-be released information with conditions. They stipulate that the journalists have to surrender their reportorial independence by agreeing to only speak with sources approved by their agency.
When NPR reporter Rob Stein was extended one of these loaded invitations, he responded by saying, “My editors are uncomfortable with the condition that we cannot seek reaction,” and asked that they be given a bit more wiggle room to speak with others. When Stein was met with a resounding no, he decided to agree to the terms and attend the briefing.
Stein wasn’t the only reporter to attend this particular briefing, as other sites such as The Wall Street Journal, The Washington Post, and The New York Times were all present. Despite agreeing to the terms, not everyone is actually comfortable with these conditions. The New York Times former Public Editor, Margaret Sullivan, said:
“I think embargoes that attempt to control sourcing are dangerous because they limit the role of the reporter whose job is to do a full look at a subject. It’s really inappropriate for a source to be telling a journalist whom he or she can and can’t talk to.”
Other tactics used by the FDA include denying major media outlets any access to the briefing prior to the public release of information, and the deliverance of half-truths when asked questions directly to hinder an investigation. Those who intend to speak with unapproved sources or announce these embargoes are met with threats.
These embargoes are often used within the science community, but none as strict as the FDA’s rules on whom reporters can confer with. The usual restrictions only focus on the date and time that a news story can be published about a particular study, which is why the stories tend to break at the same time across media outlets.
The Association of Health Care Journalists said that the close-hold embargo is “a serious obstacle to good journalism. Reporters who want to be competitive on a story will essentially have to agree to write only what the FDA wants to tell the world, without analysis or outside commentary.”
If the FDA was truly concerned about the well-being of American citizens, it wouldn’t be so shrouded in secrecy and insistent on the way news stories are covered. Instead, they put up their list of demands in an effort to protect the medical industry and pharmaceutical companies whose interests and profits matter more than having a well-informed public.

Big Pharma is killing Americans August 30, 2015

PSYCHO KILLER DRUGS June 1, 2015

Antidepressant Paxil Is Unsafe September 18, 2015

Antidepressants Scientifically Linked to Violent Behavior September 29, 2015

DEADLY PSYCHIATRY September 15, 2015

STOP PSYCHIATRIC DRUGS May 13, 2015

Antidepressants doubles the risk of suicide January 29, 2016

Psychiatric Drugs And Mass Murder: The Connection AUGUST 28, 2015

Drugged to Kill August 25, 2015

Probe link between mass shootings and psych drugs October 6, 2015

DEADLY PSYCHIATRY September 15, 2015

Impact of advertising psychiatric drugs September 15, 2016

Past and Present Psychiatric Human Rights Abuses September 15, 2016



Ti piace?

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...